Translate this page into:
Studies
PMID: 20952926
A comparative study of loratadine versus pheniramine maleate in chronic idiopathic urticaria
Ranjan C Raval, FE Bilimoria, Himanshu A Patel
Department of Skin and STD, BJ Medical College and Civil Hospital, Asharwa, Ahmedabad-380016, India
Correspondence Address:
Ranjan C Raval
100-A, Keshav Nagar, Nr. Subhas Bridge; Sabarmati, Ahmedabad-380027
India
Correspondence Address:
Ranjan C Raval
100-A, Keshav Nagar, Nr. Subhas Bridge; Sabarmati, Ahmedabad-380027
India
| How to cite this article: Raval RC, Bilimoria F E, Patel HA. A comparative study of loratadine versus pheniramine maleate in chronic idiopathic urticaria. Indian J Dermatol Venereol Leprol 1995;61:137-139 |
Copyright: (C)1995 Indian Journal of Dermatology, Venereology, and Leprology
Abstract
Fifty cases with chronic idiopathic urticaria of more than 3 months duration were selected and divided into two groups. Group ΆA' was given 10 mg loratadine once daily, while group ‘B’ was given pheniramine maleate 25 mg, twice daily for one month. All patients were followed for one month more. 48% excellent response was observed in group ‘A’ while 16% excellent response was observed in group ‘B’. Good response was observed in 24% of patients in group ‘A’, while in group ‘B’ 16% of patients had good response. No side effects were observed in Ioratadine group, while drowsiness was observed in pheniramine group.
Keywords: Urticaria, Antihistamines
